Comparison between Clinitech Laboratory IPO and S A Tech Software IPO.
Clinitech Laboratory IPO is a SME Bookbuilding IPO proposed to list at BSE SME while S A Tech Software IPO is a SME Bookbuilding proposed to list at NSE SME.
| Clinitech Laboratory IPO | S A Tech Software IPO | |
|---|---|---|
| Logo |  |  |
| Issue Category | SME | SME |
| Issue Type | IPO | IPO |
| Process Type | Fixed Price | Bookbuilding |
| Listing At | BSE SME | NSE SME |
| Lead Managers | Inventure Merchant Banker Services Pvt.Ltd. | GYR Capital Advisors Pvt.Ltd. |
| Registrar | Bigshare Services Pvt.Ltd. | Bigshare Services Pvt.Ltd. |
| Market Maker | Svcm Securities Pvt.Ltd. | Giriraj Stock Broking Pvt.Ltd. |
| DRHP | DRHP  | DRHP |
| RHP | RHP | RHP |
| Final Prospectus | Final Prospectus | Final Prospectus |
| Anchor Investor | Anchor Investor | |
| IPO Allotment URL | IPO Allotment URL | IPO Allotment URL |
The total issue size of Clinitech Laboratory IPO is up to ₹5.48 Cr whereas the issue size of the S A Tech Software IPO is up to ₹21.33 Cr. The final issue price of Clinitech Laboratory IPO is ₹96.00 per share and of S A Tech Software IPO is ₹59.00 per share.
| Clinitech Laboratory IPO | S A Tech Software IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ₹56.00 per share | |
| Issue Price (Upper) | ₹59.00 per share | |
| Issue Price (Final) | ₹96.00 per share | ₹59.00 per share |
| Discount (Retail) | ₹0.00 per share | ₹0.00 per share |
| Discount (Employee) | ||
| Market Lot Size | 1200 shares | 2000 shares |
| Fresh Issue Size | 5,71,200 shares | 36,16,000 shares |
| Fresh Issue Size (Amount) | up to ₹5.48 Cr | up to ₹21.33 Cr |
| OFS Issue Size | 0 shares | 0 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
| Issue Size Total | 5,71,200 shares | 36,16,000 shares |
| Issue Size Total (Amount) | up to ₹5.48 Cr | up to ₹21.33 Cr |
Clinitech Laboratory IPO opens on Jul 25, 2024, while S A Tech Software IPO opens on Jul 26, 2024. The closing date of Clinitech Laboratory IPO and S A Tech Software IPO is Jul 29, 2024, and Jul 30, 2024, respectively.
| Clinitech Laboratory IPO | S A Tech Software IPO | |
|---|---|---|
| Anchor Bid Date | Jul 25, 2024 | |
| Issue Open | Jul 25, 2024 | Jul 26, 2024 |
| Issue Close | Jul 29, 2024 | Jul 30, 2024 |
| Basis Of Allotment (Tentative) | Jul 30, 2024 | Jul 31, 2024 |
| Initiation of Refunds (Tentative) | Jul 31, 2024 | Aug 01, 2024 |
| Credit of Share (Tentative) | Jul 31, 2024 | Aug 01, 2024 |
| Listing date (Tentative) | Aug 01, 2024 | Aug 02, 2024 |
| Anchor Lockin End date 1 | Aug 30, 2024 | |
| Anchor Lockin End date 2 | Oct 29, 2024 |
Clinitech Laboratory IPO P/E ratio is 43.45, as compared to S A Tech Software IPO P/E ratio of 14.65.
| Clinitech Laboratory IPO | S A Tech Software IPO | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | Company Financials (Restated)
| Company Financials (Restated)
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 83.65 | 99.02 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | 61.57 | 69.45 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | 43.45 | 14.65 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ₹21.91 Cr. | ₹77.04 Cr. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | 10.95% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | 0.24 | 1.49 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ₹2.21 | ₹4.03 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | 10.46% | 17.54% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the Clinitech Laboratory IPO Retail Individual Investors (RII) are offered 2,85,600 shares while in S A Tech Software IPO retail investors are offered 2,85,600 shares. Qualified Institutional Buyers (QIB) are offered in Clinitech Laboratory IPO and 7,24,000 shares in S A Tech Software IPO.
| Clinitech Laboratory IPO | S A Tech Software IPO | |
|---|---|---|
| Anchor Investor Reservation | 10,82,000 shares | |
| Market Maker Reservation | 31,200 shares | 2,84,000 shares |
| QIB | 7,24,000 shares | |
| NII | 2,85,600 shares | 5,44,000 shares |
| RII | 2,85,600 shares | 12,66,000 shares |
| Employee | ||
| Others | ||
| Total | 5,71,200 shares | 36,16,000 shares |
Clinitech Laboratory IPO subscribed 38.96x in total, whereas S A Tech Software IPO subscribed 621.25x.
| Clinitech Laboratory IPO | S A Tech Software IPO | |
|---|---|---|
| QIB (times) | 201.29x | |
| NII (times) | 23.28x | 1,178.97x |
| Big NII (times) | ||
| Small NII (times) | ||
| RII (times) | 49.61x | 621.77x |
| Employee (times) | ||
| Other (times) | ||
| Total (times) | 38.96x | 621.25x |
